PharmaEssentia Corporation
TPEX:6446
NT$ 316.00
+ NT$0.50 (0.16%)
NT$ 316.00
+ NT$0.50 (0.16%)
End-of-day quote: 05/08/2024

PharmaEssentia financials at a glance

The revenue of PharmaEssentia is reported as 5.10562 billion New Dollars in the fiscal year 2023. The earnings were -1.93 New Dollars per share in 2023, which was 60.12 higher than 2022. And about -2.15905 billion New Dollars are reported as free cash flow in the financials of PharmaEssentia 2023. No dividends were paid to the shareholders of the PharmaEssentia stock TPEX:6446 in the financial year 2023.

NT$5.11B
Revenue
NT$-1.93
Earnings Per Share
88.04%
Gross Margin %
NT$-2,264.00M
Free Cash Flow
Revenue
5,105.62
Earnings Per Share
-1.93
Gross Margin %
88.04
Free Cash Flow
-2,264.00

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2017 2016 2015
Rev. Revenue N/A NT$5.11B NT$2.88B NT$656.51M NT$557.26M NT$305.69M NT$26.24M NT$4.04M NT$5.47M NT$11.59M
GM % Gross Margin % 89.34% 88.04% 71.82% 42.29% 33.01% 79.82% -8.23% 106.49% 79.23% -,262.89%
OM Operating Margin -54.90% -37.48% -70.37% 0.00% 0.00% -,277.80% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share NT$-2.84 NT$-1.93 NT$-4.84 NT$-10.80 NT$-8.04 NT$-3.85 NT$-4.76 NT$-4.01 NT$-4.14 NT$-4.50
Div. Dividends N/A NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00
PR % Payout Ratio % 0 -0.00% -0.00% 0 -0.00% -0.00% -0.00% -0.00% -0.00% 0
Sha. Shares N/AM 331.36M 301.55M 273.06M 260.48M 225.04M 219.09M 218.72M 218.46M 190.28M
OCF Operating Cash Flow N/A NT$-,873.00M NT$-1,505.49M NT$-2,462.07M NT$-1,455.29M NT$-,945.02M NT$-,826.84M NT$-,790.48M NT$-,657.17M NT$-,526.92M
FCF Free Cash Flow N/A NT$-2,264.00M NT$-1,817.52M NT$-2,532.40M NT$-1,536.45M NT$-1,065.75M NT$-,973.16M NT$-,815.85M NT$-,667.21M NT$-,555.81M
FCFS Free Cash Flow Per Share NT$-5.95 NT$-6.31 NT$-6.43 NT$-9.84 NT$-6.86 NT$-5.25 NT$-4.47 NT$-3.76 NT$-3.34 NT$-2.95